Disuprazole
Disuprazole (U-69167) is an orally active benzimidazole proton pump inhibitor that inhibits gastric H+/K+-ATPase with an IC50 of 2 × 10-5 M. Disuprazole reduces gastric acid secretion by inhibiting gastric proton pump activity. Disuprazole can be used in research related to gastric acid secretion and peptic ulcer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 99499-40-8
- 화학식: C16H17N3OS2
- 분자량:331.46
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
IC50 & Target
[1]|
Hog gastric H+/K+-ATPase 20 μM (IC50) |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Disuprazole (s.c. or oral administration; single dose) inhibits gastric acid secretion in Carbachol (HY-B1208)-stimulated pylorus-ligated Shay rats, with ED50 values of < 1.0 mg/kg and 2.0-5.0 mg/kg, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 99499-40-8
-
분자량 331.46
-
화학식 C16H17N3OS2
-
SMILES
O=S(CC1=NC=CC(SCC)=C1C)C2=NC3=C(N2)C=CC=C3
-
Synonyms
U-69167
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Disuprazole
- 99499-40-8
- U-69167
- U69167
- U 69167
- Proton Pump
- hydrophobic interactions
- Shay rat model
- CYP2C9 ligand
- rabbit gastric glands
- rat gastric (H+-K+)-ATPase
- extended conformation
- hydrophobic pocket of CYP2C9
- hog gastric (H+/K+)-ATPase
- water-mediated hydrogen-bonding networks
- heme
- gastric (H+/K+)-ATPase inhibitor
- Inhibitor
- inhibitor
- inhibit